Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,883,056
+$585,256 QoQ
Shares Held
15,431
+1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#1,471
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2021CallValue
$486,990
CallShares
4,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TCI Wealth Advisors, Inc. holds $24,505,177 across 8 Drug Manufacturers - General names. ABBV ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,577 | $9,797,400 | |
| 2 | LLY |
ELI LILLY & Co
|
6,824 | $8,184,911 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
15,431 | $3,883,056 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,242 | $1,187,597 | |
| 5 | AMGN |
Amgen Inc
|
1,691 | $612,344 | |
| 6 | PFE |
Pfizer Inc
|
15,257 | $367,388 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,558 | $262,631 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,661 | $209,850 |
All Filings in ABBV
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,883,056 | 15,431 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,297,800 | 15,163 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,490,184 | 15,275 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $3,558,306 | 15,368 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,826,992 | 15,230 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $3,200,627 | 15,276 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,911,081 | 16,382 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,215,961 | 16,285 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,807,439 | 16,368 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,982,615 | 16,379 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,641,153 | 17,043 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,515,834 | 16,878 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,217,925 | 16,462 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,620,680 | 16,444 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,706,644 | 16,748 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,251,372 | 16,775 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,547,510 | 16,633 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,661,035 | 16,415 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,152,589 | 15,898 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $1,736,275 | 16,096 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,965,342 | 17,448 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $486,990 | 4,500 | Call | Sole | 2021-04-29 | |
| 2021-03-31 | $1,768,206 | 16,339 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,738,937 | 16,229 | Shares | Sole | 2021-01-21 | |
| 2020-12-31 | $1,071,500 | 10,000 | Call | Sole | 2021-01-21 | |
| 2020-09-30 | $437,950 | 5,000 | Call | Sole | 2020-10-20 | |
| 2020-09-30 | $1,680,852 | 19,190 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,818,489 | 18,522 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,411,648 | 18,528 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||